NFKBIA and colorectal cancer: It has been shown that there is an enrichment of specific single-nucleotide polymorphisms and haplotypes of NFKBIA in Hodgkin's lymphoma, colorectal cancer and multiple myeloma, suggests that NFKBIA might be a tumor suppressor [24]–[26].